• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in cysts characteristics and related influence on the anatomical response after dexamethasone implant in diabetic macular oedema.糖尿病性黄斑水肿中,囊肿特征的差异及其对地塞米松植入后解剖反应的相关影响。
Eye (Lond). 2022 Jun;36(6):1329-1331. doi: 10.1038/s41433-021-01857-8. Epub 2021 Nov 24.
2
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices.两种不同 OCTA 设备在糖尿病性黄斑水肿中对囊肿和毛细血管无灌注区的表现。
Sci Rep. 2020 Jan 21;10(1):800. doi: 10.1038/s41598-020-57680-w.
3
SUSPENDED SCATTERING PARTICLES IN MOTION MAY INFLUENCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VESSEL DENSITY METRICS IN EYES WITH DIABETIC MACULAR EDEMA.运动中悬浮的散射颗粒可能会影响糖尿病黄斑水肿眼中光学相干断层扫描血管造影的血管密度测量值。
Retina. 2021 Jun 1;41(6):1259-1264. doi: 10.1097/IAE.0000000000003016.
4
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.重复玻璃体内注射地塞米松治疗抗VEGF治疗无效的糖尿病性黄斑水肿:结果及频域光学相干断层扫描预测特征
Ophthalmologica. 2018;239(4):205-214. doi: 10.1159/000485852. Epub 2018 Feb 2.
5
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.一项多中心、为期12个月的随机研究,比较地塞米松玻璃体内植入物与雷珠单抗治疗糖尿病性黄斑水肿患者的疗效。
Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):463-473. doi: 10.1007/s00417-016-3472-1. Epub 2016 Sep 8.
6
Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.评价玻璃体内注射地塞米松植入物治疗抗血管内皮生长因子治疗抵抗的糖尿病性黄斑水肿后的黄斑血管密度和中心无血管区变化的光学相干断层扫描血管造影(OCT-A)。
Int Ophthalmol. 2022 Nov;42(11):3579-3588. doi: 10.1007/s10792-022-02374-7. Epub 2022 Jun 23.
7
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.基线 SD-OCT 特征可预测糖尿病黄斑水肿模式,并可预测接受玻璃体内注射地塞米松植入物治疗的患者的形态学特征和复发时间。
Acta Diabetol. 2020 Jul;57(7):867-874. doi: 10.1007/s00592-020-01504-w. Epub 2020 Feb 29.
8
Macular and peripapillary microvasculature after dexamethasone injection in diabetic macular edema.糖尿病性黄斑水肿中地塞米松注射后的黄斑及视盘周围微血管。
Eur J Ophthalmol. 2022 Sep;32(5):2752-2759. doi: 10.1177/11206721211057695. Epub 2021 Nov 12.
9
Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.血管内皮生长因子抑制剂治疗糖尿病黄斑水肿后光学相干断层扫描血管造影的血管密度变化。
Turk J Ophthalmol. 2020 Dec 29;50(6):343-350. doi: 10.4274/tjo.galenos.2020.81592.
10
Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.地塞米松治疗无反应性糖尿病性黄斑水肿:光学相干断层扫描生物标志物。
Acta Ophthalmol. 2019 Jun;97(4):e540-e544. doi: 10.1111/aos.13935. Epub 2018 Oct 14.

引用本文的文献

1
Ensembling U-Nets for microaneurysm segmentation in optical coherence tomography angiography in patients with diabetic retinopathy.基于 U-Net 的糖尿病视网膜病变患者光学相干断层扫描血管造影中微动脉瘤分割。
Sci Rep. 2024 Sep 14;14(1):21520. doi: 10.1038/s41598-024-72375-2.
2
Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.玻璃体内注射地塞米松植入物治疗的糖尿病性黄斑水肿眼的预后影像生物标志物
J Clin Med. 2023 Feb 6;12(4):1303. doi: 10.3390/jcm12041303.

糖尿病性黄斑水肿中,囊肿特征的差异及其对地塞米松植入后解剖反应的相关影响。

Differences in cysts characteristics and related influence on the anatomical response after dexamethasone implant in diabetic macular oedema.

机构信息

IRCCS-Fondazione Bietti, Rome, Italy.

UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.

出版信息

Eye (Lond). 2022 Jun;36(6):1329-1331. doi: 10.1038/s41433-021-01857-8. Epub 2021 Nov 24.

DOI:10.1038/s41433-021-01857-8
PMID:34815531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9151728/
Abstract

PURPOSE

To assess the clinical significance of suspended scattering particles in motion (SSPiM) and different cystic phenotypes in diabetic macular oedema (DME) treated with dexamethasone implant (DEX-i).

METHODS

A retrospective review of type 2 diabetic patients with DME treated with a DEX-i was conducted. Swept-source optical coherence tomography angiography (OCTA, PLEX Elite 9000) with a 3-mm volume cube was performed. Regions of interest were delineated with Fiji software (version 2.1.0/1.53.c) in the superficial vascular complex (SVC) and deep capillary plexus (DCP) at baseline, 2- and 4-months after DEX-i. SSPiM was defined as regions of variable reflectivity with a decorrelation signal. Without a detectable decorrelation signal, its counterpart was addressed as 'corpuscular,' while hyporeflective cysts were optical empty without hyperreflective material enclosed.

RESULTS

After treatment, the hyporeflective component demonstrated substantial reabsorption in the SVC (-95.4% at 2- and -84.4% at 4-months, p < 0.01 both) and DVC (-84.4%, 2-months), with a less critical decrease of the corpuscular component in the SVC (2-months: -41.9%, p = 0.001 and 4 months: -1.8%, p = 0.73), and not significant in the DVC. SSPiM did not significantly change in the SVC and DVC neither at 2- and 4-months (p > 0.05, all).

CONCLUSIONS

After a single DEX-i, the clearance of different cystic phenotypes proceeds with resorption of hyporeflective, followed by corpuscular components. SSPiM demonstrated minimal response, indicating a severe BRB breakdown that may require repeated treatment to reach a satisfactory anatomical response.

摘要

目的

评估患有糖尿病黄斑水肿(DME)的患者在接受地塞米松植入物(DEX-i)治疗后,运动中悬浮散射颗粒(SSPiM)和不同囊样形态的临床意义。

方法

对接受 DEX-i 治疗的 2 型糖尿病 DME 患者进行回顾性研究。使用扫频源光学相干断层扫描血管造影(OCTA,PLEX Elite 9000)进行 3mm 体积立方扫描。使用 Fiji 软件(版本 2.1.0/1.53.c)在基线、DEX-i 治疗后 2 个月和 4 个月时在浅层血管复合体(SVC)和深层毛细血管丛(DCP)中划定感兴趣区域。SSPiM 被定义为具有去相关信号的可变反射率区域。如果没有检测到去相关信号,则将其对应物称为“颗粒状”,而低反射性囊肿则是光学空的,没有包含高反射性物质。

结果

治疗后,SVC(2 个月时-95.4%,4 个月时-84.4%,均 p<0.01)和 DVC(-84.4%,2 个月时)中的低反射性成分明显吸收,而 SVC 中的颗粒状成分减少程度较小(2 个月时-41.9%,p=0.001,4 个月时-1.8%,p=0.73),DVC 中则无显著变化。SVC 和 DVC 中的 SSPiM 在 2 个月和 4 个月时均无显著变化(均 p>0.05)。

结论

单次 DEX-i 后,不同囊样形态的清除过程为先吸收低反射性成分,再吸收颗粒状成分。SSPiM 反应最小,表明严重的 BRB 破裂,可能需要重复治疗才能达到满意的解剖学反应。